ANN C. MILLER, M.D. - Corporate Board Profile

INOVIO PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2019-03-25	Ann C. Miller, M.D. joined our Board in March 2019 and qualifies to serve on our Board as a result of her years of experience in the pharmaceutical industry and her clinical training. Dr. Miller worked at Sanofi S.A. from 2012 until her retirement in September 2018, serving as Vice President of Marketing and Vice President of Global Marketing, Oncology Division. From 2009 to 2011, Dr. Miller served as Senior Vice President of Pharmaceutical Services at Eisai Co., Ltd., leading its Primary Care and Specialty Business unit. Dr. Miller previously served in management roles in global marketing at Amgen Inc. and in positions of increasing responsibility at Merck & Co., Inc. over a period of 16 years. Dr. Miller received an M.D. from the Duke University School of Medicine and a B.A. in chemistry with honors from Duke University. She is a member of the Duke University Medical Alumni Council.
2020-03-27	Ann C. Miller, M.D. joined our Board in March 2019 and brings to the Board her years of commercial experience in the biopharmaceutical industry and her clinical training. Dr. Miller worked at Sanofi S.A. from 2012 until her retirement in September 2018, serving as Vice President of Marketing and Vice President of Global Marketing, Oncology Division. From 2009 to 2011, Dr. Miller served as Senior Vice President at Eisai Co., Ltd. leading the Primary Care and Specialty Business unit and then Pharmaceutical Services. Dr. Miller previously served in management roles in global and U.S. marketing at Amgen, Inc. for five years and in positions of increasing responsibility at Merck & Co., Inc. over 16 years. Dr. Miller has served on the board of directors of the publicly traded company Puma Biotechnology, Inc. since November 2019. Dr. Miller received an M.D. from the Duke University School of Medicine and a B.A. in chemistry, summa cum laude, from Duke University.
2021-03-25	Ann C. Miller, M.D. joined our Board in March 2019 and qualifies to serve on our Board as a result of her years of commercial experience in the biopharmaceutical industry and her clinical training. Dr. Miller worked at Sanofi S.A. from 2012 until her retirement in September 2018, serving as Vice President of Marketing and Vice President of Global Marketing, Oncology Division. From 2009 to 2011, Dr. Miller served as Senior Vice President at Eisai Co., Ltd. leading the Primary Care and Specialty Business unit and then Pharmaceutical Services. Dr. Miller previously served in management roles in global and U.S. marketing at Amgen, Inc. for five years and in positions of increasing responsibility at Merck & Co., Inc. over 16 years. Dr. Miller has served on the board of directors of the publicly traded companies Puma Biotechnology, Inc. since November 2019 and Allena Pharmaceuticals since October 2020. Dr. Miller received an M.D. from the Duke University School of Medicine and a B.A. in chemistry, summa cum laude, from Duke University.
2022-03-25	Ann C. Miller, M.D. Age: 64 Director Since: 2019 Director The members of the Audit Committee currently are Lota S. Zoth (Chair), Simon X. Benito and Ann C. Miller. The members of the Compensation Committee currently are Wendy L. Yarno (Chair), Ann C. Miller, Jay P. Shepard and Lota S. Zoth. Director Compensation Table Ann C. Miller, M.D. Fees Earned or Paid in Cash ($): 77,000 Stock Awards ($): 112,140 Option Awards ($): 124,805 Total ($): 313,945
2023-03-28	Ann C. Miller, M.D. Age: 65 Director Since: 2019 Director The members of the Audit Committee currently are Lota S. Zoth (Chair), Simon X. Benito and Ann C. Miller. The members of the Compensation Committee currently are Wendy L. Yarno (Chair), Ann C. Miller, Jay P. Shepard and Lota S. Zoth. Director Compensation Table Ann C. Miller, M.D. Fees Earned or Paid in Cash ($): 77,500 Stock Awards ($): 35,910 Option Awards ($): 40,434 Total ($): 153,844
2023-11-28	Directors and Named Executive Officers: Ann C. Miller, M.D.
2024-04-11	Ann C. Miller, M.D. Age: 66 Director Since: 2019 Dr. Miller worked at Sanofi S.A. from 2012 until her retirement in 2018. The members of the Compensation Committee currently are Wendy L. Yarno (Chair), Ann C. Miller and Lota S. Zoth. Director Compensation Table Ann C. Miller, M.D. Fees Earned or Paid in Cash ($): 75,000 Stock Awards ($): 20,014 Option Awards ($): 21,171 All Other Compensation ($): 10,750 Total ($): 126,935
2025-04-07	Ann C. Miller, M.D., Age: 67, Director. No committee memberships. Total compensation: $156,641 (includes $39,300 consulting fees).